A brief summary of the WHO 2021 classification of adult diffuse gliomas
The World Health Organization (WHO) classification system for central nervous system (CNS) tumors provides a distinct framework for differentiating these tumors from other types. Notably, gliomas are the most common and clinically significant primary brain tumors. The 2021 update of the WHO classifi...
Saved in:
| Main Authors: | Tien-Li Lan, Shih-Chieh Lin, Yi-Wei Chen, Yi-Yen Lee |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-09-01
|
| Series: | Tungs’ Medical Journal |
| Subjects: | |
| Online Access: | https://journals.lww.com/tmj/fulltext/2024/09001/a_brief_summary_of_the_who_2021_classification_of.2.aspx |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The relationship between IDH, P53 mutations, MGMT methylation with characteristics in high grade glioma patients
by: Duc Anh Tran, et al.
Published: (2022-07-01) -
Novel metabolic subtypes in IDH-mutant gliomas: implications for prognosis and therapy
by: Peng Wang, et al.
Published: (2025-04-01) -
Scaffold modification and synthesis routes for targeting mutant IDH 1: a review
by: Vasavi S. Pai, et al.
Published: (2025-07-01) -
Predicting p53 Status in IDH‐Mutant Gliomas Using MRI‐Based Radiomic Model
by: Jiamin Li, et al.
Published: (2025-08-01) -
Case report: Pseudoprogression mimicking neoplastic recurrence three months after completion of proton beam therapy for an IDH-mutant astrocytoma CNS WHO grade 3
by: Liv Cathrine Heggebø, et al.
Published: (2025-01-01)